Guilin Wang: Difference between revisions
Weiping Gao (talk | contribs) (New page: {{Gao_lab}} '''Guilin Wang''' ===Education=== 2006-2011, Ph.D, Chemical Engineering, University of Alberta 2003-2006, M.Sc, Materials Science and Engineering, Tsinghua University 1999-2...) |
Weiping Gao (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
2006-2011, Ph.D, Chemical Engineering, University of Alberta | 2006-2011, Ph.D, Chemical Engineering, University of Alberta | ||
2003-2006, M.Sc, Materials Science and Engineering, Tsinghua University | 2003-2006, M.Sc, Materials Science and Engineering, Tsinghua University | ||
1999-2003, B.Eng, Polymer Materials and Engineering, Beijing Technology & Business University | 1999-2003, B.Eng, Polymer Materials and Engineering, Beijing Technology & Business University | ||
| Line 12: | Line 14: | ||
1. Biomaterials, tissue engineering; | 1. Biomaterials, tissue engineering; | ||
2. Biopolymer synthesis, bioconjugation chemistry; | 2. Biopolymer synthesis, bioconjugation chemistry; | ||
3. Nanomedicine, drug delivery, targeting and controlled release. | 3. Nanomedicine, drug delivery, targeting and controlled release. | ||
===Publications=== | ===Publications=== | ||
G Wang, NZ Mostafa, V Incani C Kucharski, H Uludag. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. Journal of Biomedical Materials Research A. 2012, 100: 684-693 | [1] G Wang, NZ Mostafa, V Incani C Kucharski, H Uludag. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. Journal of Biomedical Materials Research A. 2012, 100: 684-693. | ||
G Wang, ME Babadagli, H Uludag. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds. Molecular Pharmaceutics. 2011, 8: 1025–1034 | |||
HD Singh, G Wang, H Uludağ, and LD Unsworth. Poly-L-lysine coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. ACTA Biomaterialia. 2010, 6: 4277-4284. | [2] G Wang, ME Babadagli, H Uludag. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds. Molecular Pharmaceutics. 2011, 8: 1025–1034. | ||
G Wang, C Kucharski, X Lin, H. Uludag. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Journal of Drug Targeting. 2010, 18: 611-626. | |||
G Wang, K Siggers, S Zhang, H Jiang, Z Xu, RF Zernicke, J Matyas, H Uludag. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharmaceutical Research. 2008. 25: 2896-2909 | [3] HD Singh, G Wang, H Uludağ, and LD Unsworth. Poly-L-lysine coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. ACTA Biomaterialia. 2010, 6: 4277-4284. | ||
G Wang, H Uludag. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opinion on Drug Delivery. 2008. 5: 499-515. | |||
S Zhang, G Wang, X Lin, H Jennissen, M Chatzinikolaidou, HP Jennissen, M Laub, H Uludag. Polyethylenimine-coated albumin nanoparticles for BMP-2 Delivery. Biotechnology Progress. 2008. 24: 945-956. | [4] G Wang, C Kucharski, X Lin, H. Uludag. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Journal of Drug Targeting. 2010, 18: 611-626. | ||
[5] G Wang, K Siggers, S Zhang, H Jiang, Z Xu, RF Zernicke, J Matyas, H Uludag. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharmaceutical Research. 2008. 25: 2896-2909. | |||
[6] G Wang, H Uludag. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opinion on Drug Delivery. 2008. 5: 499-515. | |||
[7] S Zhang, G Wang, X Lin, H Jennissen, M Chatzinikolaidou, HP Jennissen, M Laub, H Uludag. Polyethylenimine-coated albumin nanoparticles for BMP-2 Delivery. Biotechnology Progress. 2008. 24: 945-956. | |||
Latest revision as of 00:49, 19 September 2012
Guilin Wang
Education
2006-2011, Ph.D, Chemical Engineering, University of Alberta
2003-2006, M.Sc, Materials Science and Engineering, Tsinghua University
1999-2003, B.Eng, Polymer Materials and Engineering, Beijing Technology & Business University
Research Interest
1. Biomaterials, tissue engineering;
2. Biopolymer synthesis, bioconjugation chemistry;
3. Nanomedicine, drug delivery, targeting and controlled release.
Publications
[1] G Wang, NZ Mostafa, V Incani C Kucharski, H Uludag. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. Journal of Biomedical Materials Research A. 2012, 100: 684-693.
[2] G Wang, ME Babadagli, H Uludag. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds. Molecular Pharmaceutics. 2011, 8: 1025–1034.
[3] HD Singh, G Wang, H Uludağ, and LD Unsworth. Poly-L-lysine coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. ACTA Biomaterialia. 2010, 6: 4277-4284.
[4] G Wang, C Kucharski, X Lin, H. Uludag. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Journal of Drug Targeting. 2010, 18: 611-626.
[5] G Wang, K Siggers, S Zhang, H Jiang, Z Xu, RF Zernicke, J Matyas, H Uludag. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharmaceutical Research. 2008. 25: 2896-2909.
[6] G Wang, H Uludag. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opinion on Drug Delivery. 2008. 5: 499-515.
[7] S Zhang, G Wang, X Lin, H Jennissen, M Chatzinikolaidou, HP Jennissen, M Laub, H Uludag. Polyethylenimine-coated albumin nanoparticles for BMP-2 Delivery. Biotechnology Progress. 2008. 24: 945-956.
